Literature DB >> 10334148

Leukocytosis in acute pulmonary embolism.

A Afzal1, H A Noor, S A Gill, C Brawner, P D Stein.   

Abstract

PURPOSE: The purpose of this investigation is to assess the level of leukocytosis in acute pulmonary embolism (PE).
BACKGROUND: Limited data exist regarding leukocytosis in acute PE. One reason that the prevalence of leukocytosis in acute PE is unknown, despite an extensive number of investigations of PE, may relate to the fact that acute PE is usually associated with other conditions that themselves may cause leukocytosis.
METHODS: Hospital records of 386 patients with a diagnosis of acute PE were reviewed retrospectively. Patients with no other possible or definite cause of leukocytosis were analyzed separately. A diagnosis of PE was made by a high-probability interpretation of the ventilation/perfusion lung scan or pulmonary angiogram.
RESULTS: Among patients with PE in whom other possible or defined causes for leukocytosis were eliminated, 52 of 266 (20%) had a WBC count > 10,000/mm3. None had a WBC count that was > or = 20,000/mm3. Patients with the pulmonary hemorrhage/infarction syndrome had an increased WBC count in 32 of 183 (17%) vs 20 of 83 (24%) in patients who did not have pulmonary hemorrhage/infarction syndrome (not significant).
CONCLUSION: A modest leukocytosis may accompany (and possibly be caused by) PE. Its presence should not dissuade the clinician from objectively pursuing the diagnosis of PE.

Entities:  

Mesh:

Year:  1999        PMID: 10334148     DOI: 10.1378/chest.115.5.1329

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  The Shakespearean principle revisited.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2012

3.  Assessment of Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Pulmonary Embolism.

Authors:  Mehmet Baran Karataş; Göktürk İpek; Tolga Onuk; Barış Güngör; Gündüz Durmuş; Yiğit Çanga; Yasin Çakıllı; Osman Bolca
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

4.  Acute and Chronic Pulmonary Emboli.

Authors:  Peter F. Fedullo; Douglas M. Humber
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-04

5.  Advances in the diagnosis and treatment of acute pulmonary embolism.

Authors:  Victor F Tapson
Journal:  F1000 Med Rep       Date:  2012-05-02

6.  Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.

Authors:  Eric S Kim; Andrea M Baran; Esther L Mondo; Thomas D Rodgers; Gradon C Nielsen; David W Dougherty; Kishan J Pandya; David Q Rich; Edwin van Wijngaarden
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

7.  Pulmonary Embolism Presenting as Abdominal Pain: An Atypical Presentation of a Common Diagnosis.

Authors:  Hasan Rehman; Elizabeth John; Payal Parikh
Journal:  Case Rep Emerg Med       Date:  2016-08-24

8.  Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism.

Authors:  Nuri Köse; Tarık Yıldırım; Fatih Akın; Seda Elçim Yıldırım; İbrahim Altun
Journal:  Bosn J Basic Med Sci       Date:  2020-05-01       Impact factor: 3.363

9.  Fever is associated with higher morbidity and clot burden in patients with acute pulmonary embolism.

Authors:  Muhammad Saad; Danial H Shaikh; Nikhitha Mantri; Ahmed Alemam; Aiyi Zhang; Muhammad Adrish
Journal:  BMJ Open Respir Res       Date:  2018-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.